FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role
FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role
Active, not recruiting · NCT04333524 · Registry updated 2026-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasm | Active, not recruiting | Not stated | 2026-07-24 | NCT04333524 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| International Extranodal Lymphoma Study Group (IELSG) | 11 |
25 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.